Depomed Inc (NASDAQ:DEPO)

6.74
Delayed Data
As of May 24
 +0.04 / +0.60%
Today’s Change
4.31
Today|||52-Week Range
11.27
-16.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues100.5M95.4M94.4M128.4M
 
 
 
 
 
Cost of Goods Sold19.1M16.8M16.8M10.6M
 
 
 
 
 
Depreciation And Amortization26.3M26.3M26.5M26.9M
 
 
 
 
 
 
Operating ExpensesGross Income55.0M52.3M51.2M90.9M
 
 
 
 
 
General Expenses56.8M52.0M49.7M30.8M
 
 
 
 
 
Research And Development5.6M1.8M1.3M1.5M
 
 
 
 
 
Total Operating Expenses102.2M95.2M93.0M68.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.8M257.0K1.4M60.1M
 
 
 
 
 
Extraordinary Credit1.1M1.4M166.0K242.0K
 
 
 
 
 
Extraordinary Charge-9.1M-655.0K-34.9M-9.0M
 
 
 
 
 
Interest Expense On Debt17.5M17.6M17.8M18.1M
 
 
 
 
 
Other Expenses0.000.0017.1M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.9M-16.5M-34.0M33.5M
 
 
 
 
 
Income Taxes-249.0K-513.0K-870.0K-325.0K
 
 
 
 
 
Net Income-26.7M-16.0M-33.1M33.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS62.5M63.0M63.1M63.5M
 
 
 
 
 
Shares To Calculate EPS Diluted62.5M63.0M63.1M81.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.25-$0.52$0.48
 
 
 
 
 
EPS Diluted-$0.43-$0.25-$0.52$0.48